|
|
|
Volumn 5, Issue 11, 1999, Pages 3346-3348
|
|
Drug resistance: Still on the learning curve
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BIRICODAR;
BUTYRIC ACID;
CYCLOSPORIN;
CYCLOSPORIN A;
CYTARABINE;
DAUNORUBICIN;
DNA TOPOISOMERASE (ATP HYDROLYSING);
DOXORUBICIN;
ELACRIDAR;
GLYCOPROTEIN P;
IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;
PROTEIN P53;
QUINIDINE;
RETINOIC ACID;
TRANSCRIPTION FACTOR;
UNCLASSIFIED DRUG;
VALSPODAR;
VERAPAMIL;
CANCER SURVIVAL;
CLINICAL TRIAL;
EDITORIAL;
GENE;
GENE EXPRESSION;
GENE REARRANGEMENT;
HUMAN;
MULTIDRUG RESISTANCE;
NONHUMAN;
PRIORITY JOURNAL;
ANTINEOPLASTIC AGENTS;
DRUG RESISTANCE, MULTIPLE;
GENES, MDR;
HUMANS;
NEOPLASM METASTASIS;
NEOPLASMS;
P-GLYCOPROTEIN;
SARCOMA;
|
|
EID: 0032711516
PISSN: 10780432
EISSN: None
Source Type: Journal
DOI: None Document Type: Editorial |
|
Times cited : (17)
|
|
References (22)
|
